Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Background

A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 7 PhD students to completion, and is currently an advisor to 2 PhD students.

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc command.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Not available for supervision

Fields of research

Biomedical and Clinical Sciences Biostatistics Health Sciences Mathematical Sciences Statistics

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Clinical trials

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes considered, significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations and the anticipated width of 95% confidence intervals.

  • Meta-analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. He advocates for the reporting of tau (or exp(tau) for ratios) rather than tau^2 as it better facilitates understanding of heterogeneity estimates.

Search Professor Mark Chatfield’s works on UQ eSpace

276 works between 2004 and 2026
All (276) Journal Article (215) Conference Publication (60) Book Chapter (1)

201 - 220 of 276 works

2015

Journal Article

PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia

Binks, Michael J., Moberley, Sarah A., Balloch, Anne, Leach, Amanda J., Nelson, Sandra, Hare, Kim M., Wilson, Cate, Morris, Peter S., Nelson, Jane, Chatfield, Mark D., Tang, Mimi L. K., Torzillo, Paul, Carapetis, Jonathan R., Mulholland, E. Kim and Andrews, Ross M. (2015). PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia. Vaccine, 33 (48), 6579-6587. doi: 10.1016/j.vaccine.2015.10.101

PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia

2015

Journal Article

Hyperfiltration in Indigenous Australians with and without diabetes

Ekinci, Elif I., Hughes, Jaquelyne T., Chatfield, Mark D., Lawton, Paul D., Jones, Graham R. D., Ellis, Andrew G., Cass, Alan, Thomas, Mark, MacIsaac, Richard J., O'Dea, Kerin, Jerums, George and Maple-Brown, Louise J. (2015). Hyperfiltration in Indigenous Australians with and without diabetes. Nephrology Dialysis Transplantation, 30 (11), 1877-1884. doi: 10.1093/ndt/gfv230

Hyperfiltration in Indigenous Australians with and without diabetes

2015

Journal Article

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo

Hare, K. M., Grimwood, K., Chang, A. B., Chatfield, M. D., Valery, P. C., Leach, A. J., Smith-Vaughan, H. C., Morris, P. S., Byrnes, C. A., Torzillo, P. J. and Cheng, A. C. (2015). Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. European Journal of Clinical Microbiology and Infectious Diseases, 34 (11), 2275-2285. doi: 10.1007/s10096-015-2480-0

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo

2015

Journal Article

Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

Leach, Amanda Jane, Wigger, Christine, Hare, Kim, Hampton, Vanya, Beissbarth, Jemima, Andrews, Ross, Chatfield, Mark, Smith-Vaughan, Heidi and Morris, Peter Stanley (2015). Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC Pediatrics, 15 (1) 162. doi: 10.1186/s12887-015-0483-8

Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

2015

Journal Article

Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community

Kearns, Therese M., Speare, Richard, Cheng, Allen C., McCarthy, James, Carapetis, Jonathan R., Holt, Deborah C., Currie, Bart J., Page, Wendy, Shield, Jennifer, Gundjirryirr, Roslyn, Bundhala, Leanne, Mulholland, Eddie, Chatfield, Mark and Andrews, Ross M. (2015). Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community. PL o S Neglected Tropical Diseases , 9 (10) e0004151, e0004151-13. doi: 10.1371/journal.pntd.0004151

Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community

2015

Journal Article

precombine: a command to examine n >= 2 datasets before combining

Chatfield, Mark D. (2015). precombine: a command to examine n >= 2 datasets before combining. Stata Journal, 15 (3) dm0081, 607-626. doi: 10.1177/1536867X1501500301

precombine: a command to examine n >= 2 datasets before combining

2015

Journal Article

Sales response to price promotions in Great Britain: effect size 1/100 of that claimed

Chatfield, Mark D. (2015). Sales response to price promotions in Great Britain: effect size 1/100 of that claimed. American Journal of Clinical Nutrition, 102 (4), 977-977. doi: 10.3945/ajcn.115.114181

Sales response to price promotions in Great Britain: effect size 1/100 of that claimed

2015

Journal Article

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

Mahon, K. L., Lin, H-M., Castillo, L., Lee, B. Y., Lee-Ng, M., Chatfield, M. D., Chiam, K., Breit, S. N., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Daly, R. J., Henshall, S. M. and Horvath, G. (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer, 112 (8), 1340-1348. doi: 10.1038/bjc.2015.74

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

2015

Journal Article

Correction: Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

Lawton, Paul D, Cunningham, Joan, Gray, Nicholas A, Chatfield, Mark D, Baade, Peter D, Murali, Karumathil and Jose, Matthew D (2015). Correction: Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?. Medical Journal of Australia, 202 (6), 297-297. doi: 10.5694/mjac14.00664

Correction: Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

2015

Journal Article

Adding measures of body composition to the CKD-EPI GFR estimating equation in indigenous Australians: The eGFR study

Maple-Brown, Louise J., Hughes, Jaquelyne T., Chatfield, Mark D., Ward, Leigh C., Piers, Leonard S., Jones, Graham R. D., Lawton, Paul D., Ellis, Andrew G., Cass, Alan, Hoy, Wendy E., O'Dea, Kerin, MacIsaac, Richard J. and Jerums, George (2015). Adding measures of body composition to the CKD-EPI GFR estimating equation in indigenous Australians: The eGFR study. American Journal of Kidney Diseases, 65 (4), 632-634. doi: 10.1053/j.ajkd.2014.11.015

Adding measures of body composition to the CKD-EPI GFR estimating equation in indigenous Australians: The eGFR study

2015

Journal Article

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial

McCallum, Gabrielle B., Morris, Peter S., Grimwood, Keith, Maclennan, Carolyn, White, Andrew V., Chatfield, Mark D., Sloots, Theo P., Mackay, Ian M., Smith-Vaughan, Heidi, McKay, Clare C., Versteegh, Lesley A., Jacobsen, Nerida, Mobberley, Charmaine, Byrnes, Catherine A. and Chang, Anne B. (2015). Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial. Frontiers in Pediatrics, 3 32, 32.1-32.9. doi: 10.3389/fped.2015.00032

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial

2015

Journal Article

Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

Lawton, Paul D., Cunningham, Joan, Zhao, Yuejen, Gray, Nicholas A., Chatfield, Mark D., Baade, Peter D., Murali, Karumathil and Jose, Matthew D. (2015). Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?. Medical Journal of Australia, 202 (4), 200-204. doi: 10.5694/mja14.00664

Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

2015

Journal Article

What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens?

Kaestli, Mirjam, Harrington, Glenda, Mayo, Mark, Chatfield, Mark D., Harrington, Ian, Hill, Audrey, Munksgaard, Niels, Gibb, Karen and Currie, Bart J. (2015). What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens?. PLoS Neglected Tropical Diseases, 9 (3) e0003635, e0003635. doi: 10.1371/journal.pntd.0003635

What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens?

2014

Journal Article

The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage

Bowen, Asha C., Tong, Steven Y. C., Chatfield, Mark D. and Carapetis, Jonathan R. (2014). The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage. BMC Infectious Diseases, 14 (1) 727. doi: 10.1186/s12879-014-0727-5

The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage

2014

Journal Article

Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial

Bowen, Asha C., Tong, Steven Y. C., Andrews, Ross M., O'Meara, Irene M., McDonald, Malcolm I., Chatfield, Mark D., Currie, Bart J. and Carapetis, Jonathan R. (2014). Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet, 384 (9960), 2132-2140. doi: 10.1016/S0140-6736(14)60841-2

Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial

2014

Journal Article

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. and Clark, S. J. (2014). Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. British Journal of Cancer, 111 (9), 1802-1809. doi: 10.1038/bjc.2014.463

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

2014

Journal Article

Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012

Tong, S. Y. C., Varrone, L., Chatfield, M. D., Beaman, M. and Giffard, P. M. (2014). Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012. Epidemiology and Infection, 143 (07), 1519-1523. doi: 10.1017/s0950268814002611

Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012

2014

Journal Article

Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules

Leach, Amanda Jane, Wigger, Christine, Andrews, Ross, Chatfield, Mark, Smith-Vaughan, Heidi and Morris, Peter Stanley (2014). Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatrics, 14 (1) 200. doi: 10.1186/1471-2431-14-200

Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules

2014

Journal Article

Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study

Maple-Brown, L. J., Ekinci, E. I., Hughes, J. T., Chatfield, M., Lawton, P. D., Jones, G. R. D., Ellis, A. G., Sinha, A., Cass, A., Hoy, W. E., O'Dea, K., Jerums, G. and Macisaac, .R. J. (2014). Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study. Diabetic Medicine, 31 (7), 829-838. doi: 10.1111/dme.12426

Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study

2014

Journal Article

Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis

Barz, Thomas, Staub, Lukas P., Melloh, Markus, Hamann, Gregor, Lord, Sarah J., Chatfield, Mark D., Bossuyt, Patrick M., Lange, Joern and Merk, Harry R. (2014). Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. Spine Journal, 14 (4), 667-674. doi: 10.1016/j.spinee.2013.06.105

Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis

Current funding

  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2028
    The clinical and cost effectiveness of the Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors (The FISS-AUSTRALIA trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2024 - 2027
    Losing touch: Exploring the neurophysiological effects of bionic sensory insole technology for balance rehabilitation
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2026
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2027
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2026
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Availability

Mr Mark Chatfield is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au